Machine Learning Application for Bleeding Risk Prediction in Patients with Atrial Fibrillation Treated with Oral Anticoagulation
Authors:
- Tsahi T. LermanTLTsahi T. Lerman
- Shmuel TiosanoSTShmuel Tiosano
- Roy BeigelRBRoy Beigel
- Michal Cohen-ShellyMCMichal Cohen-Shelly
- Ran KornowskiRKRan Kornowski
- Refael MunitzRMRefael Munitz
- David A. NaceDNDavid A. Nace
- Shuja HassanSHShuja Hassan
- Karen ScandrettKSKaren Scandrett
- Daniel E. FormanDFDaniel E. Forman
- Boris FishmanBFBoris Fishman
- 13 June 2025
- journal article
- review article
- Published by S. Karger AG in Acta Haematologica
- Vol. 148 (5) , 575-582
Abstract
Background: Atrial fibrillation (AF) is a prevalent cardiac arrhythmia associated with a significantly increased risk of systemic thromboembolism and stroke. Anticoagulation therapy, particularly with direct oral anticoagulants, has become the standard for stroke prevention but comes at the cost of an increased bleeding risk. With the introduction of effective alternatives to anticoagulation, such as percutaneous left atrial appendage occlusion, bleeding risk stratification has become essential to guide therapeutic decision-making. Conventional statistical methods have been used for bleeding risk stratification scores, such as HEMORR2HAGES, HAS-BLED, and ATRIA. However, these methods may inadequately address the multifactorial nature of bleeding risk in diverse patient populations, and their overall performance has been suboptimal. Summary and Key Messages: Recent advancements in machine learning (ML) offer promising opportunities to enhance bleeding risk prediction and optimize anticoagulation therapy. This review explores ML applications in AF patients receiving anticoagulation therapy, focusing on the development and validation of ML-based bleeding risk scores. These models have demonstrated improved predictive performance compared to traditional tools, leveraging complex datasets to identify nuanced patterns and interactions. Furthermore, ML-driven tools in warfarin management, including dose prediction, optimization of time in the therapeutic range, and the identification of drug-drug interactions, show significant potential to enhance patient safety and treatment efficacy.Keywords
This publication has 62 references indexed in Scilit:
- Using machine learning to predict the bleeding risk for patients with cardiac valve replacement treated with warfarin in hospitalizedPharmacoepidemiology and Drug Safety, 2024
- Deep Learning of Electrocardiograms in Sinus Rhythm From US Veterans to Predict Atrial FibrillationJAMA Cardiology, 2023
- Comparative Effectiveness of Machine Learning Approaches for Predicting Gastrointestinal Bleeds in Patients Receiving Antithrombotic TreatmentJAMA Network Open, 2021
- Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke PreventionCanadian Journal of Cardiology, 2016
- The HAS‐BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysisClinical Cardiology, 2015
- VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: Interaction between both genotypes affects overanticoagulationClinical Pharmacology & Therapeutics, 2006
- Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)American Heart Journal, 2006
- The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the centers for disease control and preventionBirth Defects Research Part A: Clinical and Molecular Teratology, 2003
- Oral Anticoagulants vs Aspirin in Nonvalvular Atrial FibrillationJAMA, 2002
- Impact of Atrial Fibrillation on Mortality, Stroke, and Medical CostsArchives of internal medicine (1960), 1998